Walleye Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-535,133
| Closed | -$25.7M | – | 4347 |
|
|
2025
Q3 | $24.1M | Sell |
535,133
-313,825
| -37% | -$14.7M | 0.04% | 516 |
|
|
2025
Q2 | $39.3M | Buy |
848,958
+798,669
| +1,588% | +$39.2M | 0.07% | 287 |
|
|
2025
Q1 | $3.07M | Sell |
50,289
-796,573
| -94% | -$46.4M | 0.01% | 1378 |
|
|
2024
Q4 | $47.9M | Sell |
846,862
-106,041
| -11% | -$5.92M | 0.1% | 212 |
|
|
2024
Q3 | $49.3M | Buy |
952,903
+855,568
| +879% | +$40.1M | 0.1% | 196 |
|
|
2024
Q2 | $4.04M | Sell |
97,335
-24,798
| -20% | -$1.11M | 0.01% | 1169 |
|
|
2024
Q1 | $6.62M | Sell |
122,133
-72,531
| -37% | -$3.69M | 0.01% | 949 |
|
|
2023
Q4 | $9.99M | Sell |
194,664
-119,191
| -38% | -$6.26M | 0.02% | 786 |
|
|
2023
Q3 | $18.2M | Buy |
313,855
+252,336
| +410% | +$15.5M | 0.05% | 405 |
|
|
2023
Q2 | $3.93M | Buy |
+61,519
| New | +$4.13M | 0.01% | 1136 |
|
|
2023
Q1 | – | Sell |
-233,024
| Closed | -$16.4M | – | 4865 |
|
|
2022
Q4 | $16.8M | Buy |
233,024
+132,734
| +132% | +$10M | 0.05% | 436 |
|
|
2022
Q3 | $7.13M | Sell |
100,290
-17,433
| -15% | -$1.26M | 0.02% | 799 |
|
|
2022
Q2 | $9.06M | Buy |
+117,723
| New | +$8.97M | 0.03% | 672 |
|
|
2022
Q1 | – | Sell |
-123,293
| Closed | -$8.28M | – | 5344 |
|
|
2021
Q4 | $7.69M | Buy |
123,293
+75,409
| +157% | +$4.42M | 0.03% | 745 |
|
|
2021
Q3 | $2.83M | Buy |
47,884
+35,584
| +289% | +$2.34M | 0.01% | 1324 |
|
|
2021
Q2 | $822K | Buy |
+12,300
| New | +$802K | ﹤0.01% | 2342 |
|
|
2021
Q1 | – | Sell |
-245,930
| Closed | -$15.3M | – | 4816 |
|
|
2020
Q4 | $15.3M | Buy |
245,930
+180,266
| +275% | +$11.1M | 0.07% | 243 |
|
|
2020
Q3 | $3.96M | Sell |
65,664
-99,614
| -60% | -$6M | 0.02% | 699 |
|
|
2020
Q2 | $9.72M | Sell |
165,278
-308,799
| -65% | -$18.5M | 0.06% | 282 |
|
|
2020
Q1 | $26.4M | Buy |
474,077
+291,092
| +159% | +$17.8M | 0.2% | 46 |
|
|
2019
Q4 | $11.7M | Buy |
+182,985
| New | +$10.5M | 0.08% | 238 |
|
|
2019
Q1 | – | Sell |
-8,620
| Closed | -$429K | – | 4208 |
|
|
2018
Q4 | $448K | Buy |
+8,620
| New | +$463K | ﹤0.01% | 2582 |
|
|
2018
Q3 | – | Sell |
-11,553
| Closed | -$686K | – | 5278 |
|
|
2018
Q2 | $639K | Sell |
11,553
-23,847
| -67% | -$1.29M | ﹤0.01% | 2577 |
|
|
2018
Q1 | $2.24M | Sell |
35,400
-96,376
| -73% | -$6.2M | 0.01% | 1112 |
|
|
2017
Q4 | $8.07K | Sell |
131,776
-42,413
| -24% | -$2.65M | 0.04% | 424 |
|
|
2017
Q3 | $11.1K | Buy |
174,189
+86,925
| +100% | +$5.08M | 0.05% | 283 |
|
|
2017
Q2 | $4.86K | Buy |
87,264
+85,422
| +4,637% | +$4.65M | 0.03% | 596 |
|
|
2017
Q1 | $100 | Buy |
+1,842
| New | +$101K | ﹤0.01% | 3396 |
|
|
2016
Q4 | – | Sell |
-46,316
| Closed | -$2.53M | – | 4713 |
|
|
2016
Q3 | $2.5M | Buy |
+46,316
| New | +$2.98M | 0.02% | 824 |
|
|
2015
Q3 | – | Sell |
-4,425
| Closed | -$281K | – | 4966 |
|
|
2015
Q2 | $294K | Buy |
4,425
+2,801
| +172% | +$185K | ﹤0.01% | 2122 |
|
|
2015
Q1 | $105K | Sell |
1,624
-37,825
| -96% | -$2.37M | ﹤0.01% | 2633 |
|
|
2014
Q4 | $2.33M | Buy |
+39,449
| New | +$2.22M | 0.02% | 610 |
|
|
2014
Q2 | – | Sell |
-32,712
| Closed | -$1.61M | – | 3701 |
|
|
2014
Q1 | $1.7K | Sell |
32,712
-43,696
| -57% | -$2.33M | 0.02% | 563 |
|
|
2013
Q4 | $4.06M | Buy |
76,408
+70,883
| +1,283% | +$3.61M | 0.04% | 351 |
|
|
2013
Q3 | $256K | Sell |
5,525
-22,572
| -80% | -$991K | ﹤0.01% | 1559 |
|
|
2013
Q2 | $1.26M | Buy |
+28,097
| New | +$1.22M | 0.01% | 783 |
|
Other funds holding BMY
Walleye Trading's BMY Position: Q4 2025 in Review
Walleye Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 535,133 shares — an estimated $25.7M sold.
Walleye Trading first reported a position in BMY in Q2 2013 and held it in 36 quarters. The position peaked at $49.3M in Q3 2024. 2,451 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Walleye Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Walleye Trading sold 535,133 Bristol-Myers Squibb shares in Q4 2025, an estimated $25.7M.
- Walleye Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 36 quarters.
- Walleye Trading's Bristol-Myers Squibb position peaked at $49.3M in Q3 2024.
- 2,451 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.